In the present study, we demonstrated that D-aspartate acts as an in vitro and in vivo neuromodulatory molecule upon hippocampal NMDAR transmission. Accordingly, we showed that this D-amino acid, widely expressed during embryonic phase, was able to strongly influence hippocampus-related functions at adulthood. Thus, while up-regulated levels of D-aspartate increased LTP and spatial memory in four-month old adult mice, the prolonged deregulation of this molecule in thirteen-month old animals induced a substantial acceleration of age-dependent decay of synaptic plasticity and cognitive functions. Moreover, we highlighted a role for Daspartate in enhancing NMDAR-dependent synaptic plasticity through an inducible "turn-on/turnoff-like mechanism". Strikingly, we also showed that D-aspartate, when administered to aged mice, strongly rescued their physiological synaptic decay and attenuated their cognitive deterioration. In conclusion, our data suggest a tantalizing hypothesis for which this in-embryooccurring D-amino acid, might disclose plasticity windows in the aging brain. . Moreover, in vitro studies pointed out that this D-amino acid binds NMDARs 25 . However, its in vivo relevance in modulating glutamatergic neurotransmission remains unclear, since the affinity of these receptors for D-aspartate is 10 times lower than for glutamate. Based on these findings, in the present work, we challenged the hypothesis by which "forcing" higher D-aspartate levels in aged animals, this in-embryo-occurring molecule might disclose neuronal plasticity features aimed to reduce the physiological synaptic and cognitive deterioration appearing during brain aging.
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In the present study, we demonstrated that D-aspartate acts as an in vitro and in vivo neuromodulatory molecule upon hippocampal NMDAR transmission. Accordingly, we showed that this D-amino acid, widely expressed during embryonic phase, was able to strongly influence hippocampus-related functions at adulthood. Thus, while up-regulated levels of D-aspartate increased LTP and spatial memory in four-month old adult mice, the prolonged deregulation of this molecule in thirteen-month old animals induced a substantial acceleration of age-dependent decay of synaptic plasticity and cognitive functions. Moreover, we highlighted a role for Daspartate in enhancing NMDAR-dependent synaptic plasticity through an inducible "turn-on/turnoff-like mechanism". Strikingly, we also showed that D-aspartate, when administered to aged mice, strongly rescued their physiological synaptic decay and attenuated their cognitive deterioration. In conclusion, our data suggest a tantalizing hypothesis for which this in-embryooccurring D-amino acid, might disclose plasticity windows in the aging brain.
INTRODUCTION
Cognitive processes are believed to depend on changes in synaptic efficacy in certain key brain regions, including the hippocampus 1 . Among different forms of synaptic plasticity, hippocampal Nmethyl D-aspartate receptors (NMDARs)-dependent Long-Term Potentiation (LTP) has been proposed as one of the most probable neuronal substrates underlying plastic changes associated with spatial learning and memory [1] [2] [3] [4] . Accordingly, antagonists of NMDARs blocked the induction of LTP in hippocampal slices [5] [6] [7] and impaired reference memory in rats 8, 9 . Similarly, synaptic memory and cognition were influenced by genetically manipulated NMDARs. Indeed, hippocampus-related synaptic plasticity and learning were improved in mice over-expressing NR2B
subunit of these receptors 10 . Intriguingly, up-regulation of this subunit has been also described beneficial for improving cognitive functions in aged mice 11 . On the other hand, extensive evidence suggests that the hippocampus is the main brain region sensitive and vulnerable to age-related loss of functional synapses and NMDAR-mediated responses 12 . Age-related deficits in reference memory have been explored across a wide variety of species, especially in rodents, where a decline in the hippocampal ability to produce plastic synaptic changes has been documented during aging [13] [14] [15] . In this respect, alterations of synaptic connectivity and plasticity are thought to be important neurobiological determinants in causing the memory deterioration observed in old animals 12, 16 .
According to this view, aged rats exhibit reduced NMDAR binding sites, which correlate with their impairments in synaptic plasticity and cognition 17 .
Although in the past free D-amino acids were considered to be involved only in the "bacterial world", recently, mounting evidence pointed out their neuromodulatory role in controlling neuronal functions in mammals. Specifically, the D-amino acid D-serine, by acting as an endogenous coagonist at glicyne-binding-sites of NMDARs, has been shown to be able to rescue age-related impairment of NMDAR-mediated synaptic potentials in old mice and rats 18, 19 . Besides D-serine, today well characterized for its pharmacological properties and clinical implications in schizophrenia treatment 20 , another D-amino acid, namely D-aspartate, occurs in the mammalian 4 brain. In contrast to the former, the central role of the latter remains, so far, an issue of controversy.
However, neuro-anatomical and biochemical analyses indicated that in both humans and rodents, Daspartate occurs at abundant levels in developing brain to decrease at low amounts during postnatal life 21, 22 . This time-dependent regulation of D-aspartate brain content has been linked to the concomitant postnatal expression of D-Aspartate Oxidase (DDO), the only enzyme known so far to be responsible for its degradation 23, 24 . Moreover, in vitro studies pointed out that this D-amino acid binds NMDARs 25 . However, its in vivo relevance in modulating glutamatergic neurotransmission remains unclear, since the affinity of these receptors for D-aspartate is 10 times lower than for glutamate. Based on these findings, in the present work, we challenged the hypothesis by which "forcing" higher D-aspartate levels in aged animals, this in-embryo-occurring molecule might disclose neuronal plasticity features aimed to reduce the physiological synaptic and cognitive deterioration appearing during brain aging.
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RESULTS
D-aspartate triggered NMDAR-dependent and NMDAR-independent currents.
The pharmacological features of D-aspartate were studied on CA1 pyramidal neurons. NMDA induced a remarkable inward current (I NMDA ), which remained constant after repeated applications of the agonist. Perfusion with NVP, a selective NR2A blocker, and cis-PPDA, a NR2C-D antagonist, reversibly reduced I NMDA to great extent (Fig. 1a,b) . In the same neurons, I NMDA was largely blocked, in an irreversible manner, by Ro 25-6981, a selective NR2B antagonist (Fig. 1   a,b) . Similarly, also D-aspartate-mediated inward currents (I D-Asp ) were reduced by each NR2
selective antagonist ( Fig. 1 a,b) . Interestingly, while I NMDA was totally blocked by the simultaneous combination of all NR2 selective antagonists or by the non-competitive NMDAR antagonist, MK801 (Fig. 1b) , under the same conditions D-aspartate was still able to excite CA1 pyramidal neurons (Fig. 1b) . Next, we studied the calcium dynamics mediated by D-aspartate, performing
voltage-clamp recordings associated with microfluorometry with the use of a pipette solution filled with the calcium-sensitive dye fura-2. As expected, puff applications of D-aspartate caused an inward current that was associated with a transient increase of [Ca 2+ ]i (Fig. 1c) . This current was largely, but not totally, antagonized in a reversible manner by a high concentration of D-AP5 or irreversibly by MK801 (Fig. 1c) . Finally, a further set of experiments conducted in the continuous presence of MK801 showed that the residual I D-Asp remained constant even with the co-application of the sodium-dependent glutamate/aspartate transporter inhibitor DL-TBOA (Fig. 1d) . This current is rather inhibited by switching the normal ACSF solution to one not containing calcium ions (Fig.   1d) . Notably, chelation of intracellular Ca 2+ with EGTA, blockade of all glutamate receptors with CNQX and MCPG, and the use of non-specific Voltage Gated Calcium Channel (VGCC) blocker cadmium chloride, all added to the superfusion medium, did not affect the remaining Excitatory Post Synaptic Currents (EPSC) (Fig. 1d) . Therefore, our data indicate that the action of D-aspartate on CA1 pyramidal neurons occurs via Ca 2+ currents through, at least, two alternative routes based on NMDAR-dependent and NMDAR-independent pathways.
Lack of D-Aspartate Oxidase induced a dramatic acceleration of age-dependent decay of hippocampal synaptic transmission and plasticity.
We have recently demonstrated that higher D-aspartate levels, in the hippocampus of two-month old Ddo -/-mice, enhance the NMDAR-dependent form of LTP, while maintain synaptic transmission unaltered 26 . Based on this study, here we determined the age-related effect of Ddo gene ablation on synaptic transmission and plasticity in area CA1.
Firstly, we examined D-aspartate levels in the hippocampus of Ddo -/-animals and their control littermates at 4, 9 and 13 months of age. According to the pivotal role of DDO in controlling Daspartate levels, HPLC analysis indicated a strong and persistent hippocampal up-regulation of this D-amino acid content throughout all ages tested (Fig. 2a) .
Next, we measured basal synaptic transmission on hippocampal slices from mutants and controls, at the same ages at which we evaluated D-aspartate concentrations. At 4 months of age, Ddo +/+ and Ddo -/-mice showed similar trendlines (Fig. 2b) . Also at 9 months of age, both genotypes exhibited comparable fEPSP slopes and fiber volley amplitudes at all stimulus intensities tested (Fig. 2b) . In contrast, thirteen-month old Ddo -/-animals had significantly reduced maximum fEPSPs, relative to Ddo +/+ controls (Fig. 2b) . Therefore, these results show that the age-dependent decline in fast glutamatergic transmission is exacerbated in absence of DDO enzyme. We then investigated pairedpulse facilitation (PPF), a measure of short-term plasticity. Interestingly, no differences in the paired-pulse ratio between Ddo -/-and Ddo +/+ mice were observed in the three age-group tested (Fig.   2c ). Finally, we explored the effects of deregulated levels of D-aspartate on age-related LTP at CA1
synapses. At 4 months of age, we showed a significant increase in the magnitude of LTP in Ddo -/-animals, compared to control mice (Fig. 2d) . In contrast, LTP was impaired either in nine-month (Fig. 2d) and, even more severely, in thirteen-month old mutants, when compared to age-matched controls (Fig. 2d) . Interestingly, at 13 months of age, a physiological decay of LTP appeared also in Ddo +/+ mice that, in any case, never reached the dramatic impairment observed in mutant CA1 synapses (Fig. 2e) .
Ddo
-/-mice displayed spatial memory enhancement or worsening in an age-dependent fashion.
As putative behavioural correlate of hippocampal NMDAR-dependent synaptic plasticity, we investigated ontogenetic changes in learning and memory abilities of Ddo -/-mice, at 4, 9 and 13 months of age, in a reference memory task of the Morris water maze paradigm.
During acquisition phase, we found similar escape latencies between four-month old Ddo +/+ and Ddo -/-animals ( Fig. 3a) . In order to evaluate their spatial memory formation, we performed two retention tests, after a three-day (short) or five-day (long) training period. Interestingly, in probe 1, knockout mice displayed a forward ability in remembering the correct location of the platform, compared to controls (Fig. 3b) . However, after a longer training exposure, both genotypes showed a comparable bias spatial search in the target quadrant (Fig. 3c) . Then, in order to analyze the ability of the mice to erase previous spatial information and planning a new navigation strategy, we moved the platform to the opposite position. Also in the reversal phase, both groups displayed similar learning abilities (Fig. 3a) . Moreover, the results in the retention tests confirmed in Ddo -/-mice an improved spatial memory after a short training exposure, compared to controls (Fig. 3d) . In fact, although both groups showed a search preference for the new goal quadrant, Ddo -/-mice significantly spent more time in this location, compared to controls. After additional training, both genotypes showed comparable preferential search for the target quadrant (Fig. 3e) .
Also at 9 months of age, both genotypes evidenced comparable spatial learning aptitudes in both acquisition and reversal phases (Fig. 3f) . Importantly, in probe 1, Ddo -/-group did not confirm improved spatial memory, evidenced at 4 months of age (Fig. 3g) , since the correct position of the platform was acquired only after a longer training (Fig. 3h) . Moreover, in the reversal phase, spatial retention in the new goal quadrant occurred only in Ddo +/+ animals after five-day training exposure (Fig. 3i,j) , thus highlighting in mutants the occurrence of mild memory deterioration at this age.
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The worsening of cognitive aptitudes of Ddo -/-animals was further evidenced in thirteen-month old mice. While comparable spatial learning curves were observed for both genotypes during acquisition (Fig. 3k) , only Ddo +/+ animals showed preserved spatial memory abilities (Fig. 3l,m) . In the reversal phase, a prominent overall impairment in spatial learning and memory was observed in mutants (Fig. 3k,n,o) .
Alteration of hippocampal synaptic markers in Ddo -/-mice.
Here, we analysed whether synaptic and cognitive decline were mirrored by morphological variations in the hippocampus of Ddo -/-mice. First, toluidine staining showed no distinguishing abnormalities in the pyramidal cell layer and dentate gyrus (DG) of the hippocampus from Ddo
and Ddo -/-mice, at any age. This was confirmed by the counting of Neu-N-IR profiles (data not shown). A diffuse age-dependent increase in GFAP-IR (Fig. 4h,i ,m,n,s) and astrocyte hypertrophy (Fig. 4g,l) , were observed in the CA3 subfield of the hippocampus, regardless genotype.
Nevertheless, in the same area, these changes were selectively associated with a reduced immunostaining for the presynaptic marker synaptophysin in thirteen-month old Ddo -/-mice ( Fig.   4s ) and, interestingly, were anticipated by a decreased staining for the postsynaptic marker MAP2 in four-month old mutants (Fig. 4s) . Synaptophysin significantly decreased also in knockout mice in CA1/2 area, at both 4 and 13 months of age ( Fig. 4o-s) , and in DG of aged mice, compared to respective controls (Fig. 4s) . Similarly, a reduced pattern of staining for MAP2 was detected in CA1/2 field of elderly Ddo -/-mice, compared to age-matched Ddo +/+ animals (Fig. 4a,b,d,e,s) .
Remaining dendrites resulted irregular in shape and size (Fig. 4c,f) . Overall, morphological alterations found in the hippocampus of old mutants are consistent with the behavioural and electrophysiological decline observed during aging.
D-aspartate induced a transient and reversible modulatory effect on NMDAR-dependent LTP.
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To study the in vitro and in vivo consequences associated to non-physiological increased levels of D-aspartate, without interfering with Ddo gene expression, we recently developed a pharmacological mouse model based on one-month oral administration of this D-amino acid 26 .
Taking advantage of this model, we further examined the neurochemical and electrophysiological consequences of a more prolonged chronic administration. According to our previous report, we found that D-aspartate oral treatment overall resulted in a significant increase of its hippocampal content. However, despite the different time-exposure extent, we failed to detect gross differences in D-aspartate amount following moderate (3 months) and long-term (12 months) delivery periods (Fig. 5a) .
After a three-month administration, C57BL/6J treated mice showed a higher I-O trend, although not significant, compared to their untreated controls (Fig. 5b) . Similarly, chronic one-year administration of D-aspartate produced only a slight decrease in basal transmission. Indeed, differently to what observed in mutants, this effect did not reach statistical significance (Fig. 5b) , demonstrating that even prolonged oral administration of this molecule does not perturb basal synaptic responses. Also PPF was indistinguishable in all groups (Fig. 5c) . Finally, we examined the effects of higher D-aspartate levels on synaptic plasticity in area CA1. Notably, we showed that three-month D-aspartate treatment induced a robust enhancement in LTP magnitude (Fig. 5d) .
Interestingly, this plastic augmentation appeared to be regulated through an inducible mechanism, since three-week withdrawal was able to reverse this potentiating effect that was, conversely, reinstated following one-month D-aspartate re-administration (Fig. 5d) . In contrast, hippocampal slices from twelve-month chronically treated mice were dramatically unresponsive to the conditioning train, compared to age-matched controls (Fig. 5e) . Moreover, despite what was found in Ddo +/+ mice, no signs of age-dependent LTP decay was detected in thirteen-month old untreated C57BL/6J mice (Fig. 5f) . These results mirrored, to a large extent, those obtained in Ddo -/-mice, thus highlighting a common opposing time-dependent effect of chronic D-aspartate exposure on hippocampal LTP. To summarize, our data clearly point out that D-aspartate is able to modulate NMDAR-dependent LTP at CA1 synapses and, in turn, provide strong evidence about its role in influencing age-dependent changes in synaptic plasticity.
Chronic D-aspartate oral administration in C57BL/6J mice improved spatial memory in adulthood without perturbing cognitive functions in elderly phases.
Spatial learning and memory abilities in D-aspartate treated C57BL/6J mice were analyzed after its three-month or twelve-month chronic oral administration, according to the same behavioural protocol adopted for mutant animals. During acquisition and reversal phases, three-month Daspartate treatment did not produce any visible change in learning aptitudes of mice (Fig. 6a) .
Importantly, after a short training, treated mice evidenced an improvement of spatial memory, as indicated by longer search in the goal area, compared to controls (Fig. 6b) . Nevertheless, such slight difference between groups disappeared after a two-day additional training (Fig. 6c) .
Similarly, during reversal phase, treated animals showed enhanced spatial memory skills, as indicated by the longer time spent in the new goal quadrant in the probe 3, compared to non-treated mice (Fig. 6d) , while both groups were similarly able to remember the position of the new target quadrant after five-day training (Fig. 6e ).
Like the shorter treatment, also one-year D-aspartate administration did not modify spatial learning performances of C57BL/6J mice (Fig. 6f) . Nevertheless, this long-term treatment induced a lack of the previous memory enhancement seen in three-month D-aspartate-treated mice. Indeed, no differences were detected between D-aspartate-treated and untreated groups in each of the retention tests performed (Fig. 6g-j) .
D-aspartate rescued CA1 synaptic plasticity decline associated with aging.
We have previously shown that one-month oral administration of D-aspartate was able to strongly increase LTP magnitude in young animals 26 . Here, we investigated whether such short-term treatment might also be beneficial to counterbalance the age-related decay of hippocampus-11 dependent functions. Since it is known that rodent females exhibit a faster rate of deterioration in reference memory 27, 28 , we decided to utilize for this study twelve-month old C57BL/6J females.
Such females, treated for 1 month with D-aspartate, exhibited a significant increase of this D-amino acid levels in their hippocampi, compared to untreated mice (Fig. 7a) . Electrophysiological experiments indicated no main differences in basal synaptic transmission and short-term plasticity, as measured by I-O curves (Fig. 7b ) and PPF (data not shown), respectively. In contrast, we found a strong enhancement of LTP in treated mice, compared to both age-matched controls (Fig. 7c,d) and two-month old C57BL/6J females (Fig. 7c,d ). Moreover, according to gender differences relative to age-related hippocampal functions, C57BL/6J females showed a pronounced agedependent LTP decay, not seen in males (Fig. 7f ).
Finally, we explored spatial cognitive abilities of D-aspartate-treated aged females. Surprisingly, we found that treated animals displayed a better spatial learning, compared to untreated mice (Fig. 7e) .
In this regard, it is important to notice that the difference seen after the first training day exclusively derives from the second daily session since, in the first test session, mice exhibited comparable escape latencies (untreated: 84.25 ± 2.26 s; treated: 76.50 ± 4.21 s). However, according to a more relevant age-dependent mnemonic decay likely due to hormonal influences, even after a five-day training exposure, both treated and untreated mice did not remember the correct location of the platform (Fig. 7f,g ). During reversal phase, both groups showed a comparable learning profile (Fig.   7e ). Nevertheless, a mild improvement was detected at days 4 and 5 in D-aspartate treated animals.
Conversely, no differences were found in the retention tests (Figure 7h ,i).
DISCUSSION
While a relevant role for D-aspartate in controlling hormonal activity is well established 29 , its involvement in central functions, so far, remains largely unclear. Indeed, although pharmacological studies demonstrated that this D-amino acid binds NMDARs, its in vivo neuromodulatory action is still actively debated. In accordance to our previous studies performed on single cells, in CA1
pyramidal neurons 26 , here we confirmed the existence of an inward current triggered by D-aspartate, not fully suppressed by NMDAR antagonists. For the first time, we demonstrated that D-aspartatemediated excitatory currents are exclusively calcium-dependent, since they are abolished by perfusion in a calcium-free medium. We were unable, so far, to identify any putative target, since the chelation of intracellular calcium and the blockade of all glutamate receptors and VGCC never affected this persistent inward current. Therefore, besides demonstrating a direct action on NMDAR via interaction with each of NR2A-D subunits, we indicated that the physiological function of Daspartate is selectively mediated through a calcium-dependent signalling. Hence, we propose that D-aspartate in the brain acts presumably through, at least, two different pathways based on NMDAR-dependent and NMDAR-independent signalling. On the other hand, the proposed "dual" mechanism of D-aspartate action is also supported by biochemical findings which pointed out a lack of functional NMDARs in organs, like testis and adrenal glands, where high levels of this D-amino acid were also detected 21, 30 . 33 , our studies indicated a good correspondence between the biphasic age-dependent LTP changes and spatial memory abilities. In fact, while four-month old knockouts displayed enhanced spatial memory, in nine-and, even more prominently, thirteen-month old Ddo -/-animals this improvement completely disappeared and a significant worsening of cognitive abilities occurred, compared to their relative age-matched controls.
We also showed that, when D-aspartate was administered under an intermittent regimen, this Damino acid triggered a transient and reversible enhancement of LTP at CA1 synapses through an inducible "turn-on/turn-off-like mechanism". Hence, these data further corroborated a role for Daspartate in regulating NMDAR signalling and, in turn, provided an attractive possibility when considering its clinical potential.
Furthermore, similarly to aged Ddo -/-mice, long-term exposure of D-aspartate evocated a severe decay of hippocampal synaptic plasticity. However, differently to the oldest Ddo -/-mice here tested 14 (13 months), one-year D-aspartate chronic administration in C57BL/6J animals failed to produce deficits in basal transmission and reference memory.
Overall, our data strongly supported a neuromodulatory role for D-aspartate on glutamatergic transmission and, in turn, showed that, according to its properties as NMDAR agonist, nonphysiological amounts of this molecule in the brain could unmask the opposite neuronal influences exerted by this receptor 34, 35 . In fact, while physiological stimulation of NMDARs has a crucial adaptive role in brain processes such as neuronal survival and synaptic plasticity, on the other hand, their abnormal activation leads to deregulation of calcium homeostasis, responsible for loss of synaptic memory and neurotoxicity 34, 36, 37 . Consistently, altered LTP has been widely documented in hippocampal slices from several transgenic mouse models of Alzheimer Disease (AD) [38] [39] [40] [41] and in senescence-accelerated mouse strains 42 . In this line, we showed that higher D-aspartate levels render glutamatergic synapses more prone to plastic changes, in both four-month old genetic and pharmacological animal models, while the prolonged activation of NMDARs in 9-13 month old Ddo -/-mice and in long-term treated animals produced a strong accelerated rate of age-dependent synaptic plasticity deterioration.
Nevertheless, our data pointed out also a direct involvement of the specific genetic background on which genetic or pharmacological manipulation are studied 43 , 44 . In fact, C57BL/6J animals, characterized to display very high performances in hippocampus-dependent functions, represent a "difficult" mouse strain for easily detecting changes associated to aging 45 . Thus, even though Daspartate induced very strong changes on hippocampal LTP between three-and twelve-month treated animals, surprisingly, only mild, if any, differences were found in their spatial memory aptitudes.
On the contrary, based on the observations that C57BL/6J aged females manifested a more prominent hippocampal cognitive 27 and synaptic memory decline (Fig. 7c,d ), compared to males, we decided to test whether this embryonic D-amino acid may produce a "youth" influence on neuronal plasticity in this more aging-sensitive gender. Remarkably, we showed that one-month 15 oral administration of D-aspartate to one-year old females conferred considerable stronger plastic properties, relative to those observed in age-matched controls. The entity of this amelioration was even more surprising comparing the level of LTP of these D-aspartate-treated mice to that observed in two-month old untreated females. Moreover, this D-amino acid also slightly improved cognitive abilities of old females. Taken together, these evidences further extended to aged brains the ability of this endogenous D-amino acid to modulate NMDAR-dependent functions.
In conclusion, our data demonstrated an in vitro and in vivo neuromodulatory role for D-asparate in modulating synaptic plasticity and cognition and, in turn, highlighted a crucial, yet unknown, implication of DDO in controlling the age-related physiological decline of hippocampus-dependent functions. In fact, while the lack of DDO in adult mice induced an enhancement of both LTP and spatial memory, at maturity stages it determined a strong acceleration of aging processes, which resembled the synaptic and behavioural features described in AD-like animal models [38] [39] [40] [41] . In this line, also alterations in synaptic markers MAP2 and synaptophysin found in old mutant hippocampi, are consistent to those seen in APP-null mice 46 . Moreover, the in dissociable opposite age-dependent electrophysiological and behavioural phenotypes seen in Ddo -/-mice, let retain these animals as a peculiar model for studying in vivo the "Yin and Yang" consequences associated to an abnormal NMDARs signalling 34 . Nevertheless, the lack of gross cognitive alterations after a long-term Daspartate chronic administration further supported a potential interest for this D-amino acid when considering the beneficial effects of this molecule in attenuating schizophrenia-like symptoms induced by amphetamine and MK801 challenges (FE and AU unpublished data).
METHODS
Animals
Mutant mice for Ddo gene were generated as previously described 23 
HPLC analysis
Mice were killed and the hippocampus dissected and stored at -80°C. The determination of Daspartate was performed by HPLC technique, based on the diastereomeric separation of D-aspartate from the L-form and other L-amino acids, as previously described 48 . Data were analysed using ANOVA or two-tailed Student's t test and data are expressed as means ± standard error of the mean (SEM).
Morris water maze
Morris water maze was performed according to a modified version of the protocol described by
Errico et al. 26 . The apparatus consisted of a circular pool (100 cm in diameter), surrounded by threedimensional visual cues, containing opaque water at 21°C (± 1°C) with a platform (8 cm in diameter) submerged 1 cm beneath the water surface. Mice were gently handled 5 min per day for a week before the experiment. The acquisition phase consisted of 2 sessions per day (3 h interval between sessions) over a five-day period. Each session was composed of 4 trials with an inter-trial interval of approximately 5 min. On day 6, the platform was moved to the opposite position and the reversal learning was monitored for 5 additional days. Overall, 4 probe tests were performed (2 tasks per each training phase) in which animals were allowed to swim for 60 s in the absence of the platform, in order to evaluate time-dependent memory retention of mice. During acquisition phase, the first test (probe 1) was performed before starting the 4 th day of training, while the second (probe 2) was conducted at day 6, before the first session of the reversal phase. During reversal phase, the first retention task (probe 3) was done before starting the 9 th day of training, while the second (probe 4) was conducted at the end of the reversal phase, at day 11. Each retention test was conducted about 18 h after the second session of the previous day. In both acquisition and reversal phases, the time to reach the target was measured. In the probe tests, the percentage of time spent in each quadrant was recorded. A computerized video tracking system (Videotrack, Viewpoint S.A.,
Champagne au Mont d'Or, France) was used for all mentioned parameters. In the acquisition phase, the measure of the escape latency was used as dependent variable and data were examined using ). At 9 months of age, this tendency was inverted and LTP values were 39.7 ± 9.3% above baseline in control (n = 8), and 19.5 ± 2.5% in mutant slices (n = 7). Finally, fEPSP was potentiated to only 8.5 ± 12.5% in thirteen-month old Ddo -/-mice (n = 6), compared to 30.07 ± 10.4% in age-matched Ddo +/+ animals (n = 7). At 9 and 13 months of age, the genotypic effect on LTP was always significant (p < 0.001). The arrow represents the HFS used to induce potentiation (e) Summary graph (mean ± SEM) showing genotype-and age-effects on the fEPSP slopes (% of baseline) quantified 50-60 min after HFS (100 Hz for 1 s). We are also grateful to Mrs M. Hipwood and Mrs C. Melone for the preparation of the manuscript.
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